Table 3 Clinicopathological correlation between average semiquantitative miR-211 intensity and cytological atypia in dysplastic nevi
From: microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis
Case no. | Diagnostic group | Ave. miR-211 Intensity | miR-211 score | Age | Sex | Location | Cytological atypia |
|---|---|---|---|---|---|---|---|
1 | Dysplastic nevus | 1.5 | High | 50 | F | Shin, superior | Mild |
2 | Dysplastic nevus | 2.0 | High | 50 | F | Shin, inferior | Moderate |
3 | Dysplastic nevus | 2.8 | High | 50 | F | Left clavicle | Mild |
4 | Dysplastic nevus | 2.8 | High | 50 | F | Right shoulder | Mild |
5 | Dysplastic nevus | 1.8 | High | 39 | M | Upper back | Mild |
6 | Dysplastic nevus | 1.8 | High | 39 | M | Mid-back | Moderate |
7 | Dysplastic nevus | 2.0 | High | 39 | M | Lateral mid-back | Moderate |
8 | Dysplastic nevus | 0.5 | Low | 39 | M | Left mid-back | Moderate |
9 | Dysplastic nevus | 2.5 | High | 39 | M | Chest | Moderate |
10 | Dysplastic nevus | 2.0 | High | 41 | M | Upper back, superior | Moderate |
11 | Dysplastic nevus | 1.8 | High | 41 | M | Upper back, inferior | Moderate |
12 | Dysplastic nevus | 2.0 | High | 41 | M | Lower back | Mild |
13 | Dysplastic nevus | 2.0 | High | 71 | M | Lower back | Moderate |
14 | Dysplastic nevus | 2.8 | High | 48 | F | Mid back | Moderate |
15 | Dysplastic nevus | 1.0 | Low | 48 | F | Lateral mid-back | Mild |
16 | Dysplastic nevus | 2.3 | High | 32 | F | Upper back | Moderate |
17 | Dysplastic nevus | 1.3 | Low | 69 | M | Abdomen | Moderate |
18 | Dysplastic nevus | 2.5 | High | 24 | F | Abdomen | Moderate |
19 | Dysplastic nevus | 2.5 | High | 79 | M | Right lower back | Moderate |
20 | Dysplastic nevus | 3.0 | High | 26 | F | Left inferior frontal scalp | Severe |
21 | Dysplastic nevus | 2.0 | High | 60 | F | Back | Moderate |
Mean | 2.0±0.6 | ||||||
